UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 110

Sortiert nach

P1289 CAN COMBINATION HCV PREVENTION INTERVENTIONS IN THE DAA ERA RESULT IN DRAMATIC REDUCTIONS IN HCV PREVALENCE? A MODELING ANALYSIS IN SETTINGS WITH EXISTING HARM REDUCTION

Journal of hepatology, 2014-04, Vol.60 (1), p.S519-S519

2014

Volltextzugriff (PDF)

P1292 EVIDENCE OF CONTINUED INJECTING DRUG USE AFTER ATTAINING SUSTAINED TREATMENT-INDUCED CLEARANCE OF THE HEPATITIS C VIRUS: IMPLICATIONS FOR RE-INFECTION

Journal of hepatology, 2014-04, Vol.60 (1), p.S520-S521

2014

Volltextzugriff (PDF)

Comparing Individual and Population Prevention Benefits of Early Direct-Acting Antiviral Treatment for HCV

Journal of hepatology, 2016, Vol.64 (2), p.S464-S464

2016

Volltextzugriff (PDF)

Heart Failure Related Hospitalizations in Children with Single Ventricle Heart Disease: Prevalence, Risk Factors for Mortality, and Economic Burden

The Journal of heart and lung transplantation, 2016-04, Vol.35 (4), p.S398-S398

2016

Volltextzugriff (PDF)

P734 A SYSTEMATIC REVIEW OF INTERVENTIONS TO REDUCE ALCOHOL CONSUMPTION AMONG INDIVIDUALS WITH CHRONIC HCV INFECTION

Journal of hepatology, 2014-04, Vol.60 (1), p.S314-S315

2014

Volltextzugriff (PDF)

Potential for reported needlestick injury prevention among healthcare workers through safety device usage and improvement of guideline adherence: expert panel assessment

The Journal of hospital infection, 2006-08, Vol.63 (4), p.445-451

2006

Volltextzugriff (PDF)

1119 QUANTIFYING THE EXTENT OF CIRRHOSIS ATTRIBUTABLE TO ALCOHOL AMONG PATIENTS CHRONICALLY INFECTED WITH HEPATITIS C: IMPLICATIONS FOR TREATMENT COST-EFFECTIVENESS STUDIES

Journal of hepatology, 2012-04, Vol.56, p.S441-S441

2012

Volltextzugriff (PDF)

Heart Failure Related Hospitalizations in Children With Single Ventricle Heart Disease in the United States: Costly and Getting More Expensive

Journal of cardiac failure, 2012-08, Vol.18 (8), p.S73-S73

2012

Volltextzugriff (PDF)

867 ARE CURRENT TREATMENT RATES SUFFICIENT TO REDUCE HCV PREVALENCE AMONG PEOPLE WHO INJECT DRUGS? MODEL PROJECTIONS IN SEVEN UK SETTINGS

Journal of hepatology, 2013-04, Vol.58, p.S356-S356

2013

Volltextzugriff (PDF)

795 MODELLING THE IMPACT OF ANTIVIRAL THERAPY ON THE FUTURE HEALTH AND ECONOMIC BURDEN OF CHRONIC HEPATITIS C IN SCOTLAND

Journal of hepatology, 2008, Vol.48, p.S297-S297

2008

Volltextzugriff (PDF)

111: Safety and Effectiveness of Intravenous Prochlorperazine for Intractable Vomiting in Children With Gastroenteritis

Annals of emergency medicine, 2008, Vol.52 (4), p.S76-S76

2008

Volltextzugriff (PDF)

Late diagnosis of chronic liver disease in a community cohort (UK biobank): determinants and impact on subsequent survival

Public health (London), 2020-10, Vol.187, p.165-171

2020

Volltextzugriff (PDF)

MR elastography-based staging of liver fibrosis in Fontan procedure associated liver disease is confounded by effects of venous congestion

Clinical radiology, 2022-10, Vol.77 (10), p.e776-e782

2022

Volltextzugriff (PDF)

Increased risk of non-fatal overdose associated with non-prescribed benzodiazepine use in Scotland, UK

The International journal of drug policy, 2023-10, p.104236-104236, Article 104236

2023

Volltextzugriff (PDF)

Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic

Public health (London), 2021-01, Vol.190, p.132-134

2021

Volltextzugriff (PDF)

National population prevalence of antibodies to SARS-CoV-2 in Scotland during the first and second waves of the COVID-19 pandemic

Public health (London), 2021-09, Vol.198, p.102-105

2021

Volltextzugriff (PDF)

National population prevalence of antibodies to SARS-CoV-2 among pregnant women in Scotland during the second wave of the COVID-19 pandemic: a prospective national serosurvey

Public health (London), 2021-10, Vol.199, p.17-19

2021

Volltextzugriff (PDF)

FRI-420 - Comparing Individual and Population Prevention Benefits of Early Direct-Acting Antiviral Treatment for HCV

Journal of hepatology, 2016, Vol.64 (2), p.S464-S464

2016

Volltextzugriff (PDF)

Identifying former injecting drug users infected with hepatitis C: an evaluation of a general practice-based case-finding intervention

Journal of public health (Oxford, England), 2012-03, Vol.34 (1), p.14-23

2012

Volltextzugriff (PDF)

O.143 Monitoring of end-stage liver disease associated with hepatitis C virus (HCV) infection in Scotland: Record-linkage study

Journal of clinical virology, 2006, Vol.36, p.S44-S44

2006

Volltextzugriff (PDF)

P71 Choosing an alternate light source with a corresponding dose in photodynamic therapy (it's not rocket science, but it is quantum physics!): determining the PpIX activiation effect

Melanoma research, 2010-06, Vol.20, p.e74

2010

Volltextzugriff (PDF)

Costs of running a universal adolescent hepatitis B vaccination programme

Vaccine, 2005-12, Vol.23 (48), p.5624-5631

2005

Volltextzugriff (PDF)

Ablative Skin Resurfacing

Basics in Dermatological Laser Applications, 2011, Vol.42, p.40-47

2011

Volltextzugriff (PDF)

Laser Principles

Basics in Dermatological Laser Applications, 2011, Vol.42, p.7-23

2011

Volltextzugriff (PDF)

Determinants of universal adolescent hepatitis B vaccine uptake

Archives of disease in childhood, 2004-11, Vol.89 (11), p.1041-1042

2004

Volltextzugriff (PDF)

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(103)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(110)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

P1289 CAN COMBINATION HCV PREVENTION INTERVENTIONS IN THE DAA ERA RESULT IN DRAMATIC REDUCTIONS IN HCV PREVALENCE? A MODELING ANALYSIS IN SETTINGS WITH EXISTING HARM REDUCTION

P1292 EVIDENCE OF CONTINUED INJECTING DRUG USE AFTER ATTAINING SUSTAINED TREATMENT-INDUCED CLEARANCE OF THE HEPATITIS C VIRUS: IMPLICATIONS FOR RE-INFECTION

Comparing Individual and Population Prevention Benefits of Early Direct-Acting Antiviral Treatment for HCV

Heart Failure Related Hospitalizations in Children with Single Ventricle Heart Disease: Prevalence, Risk Factors for Mortality, and Economic Burden

P734 A SYSTEMATIC REVIEW OF INTERVENTIONS TO REDUCE ALCOHOL CONSUMPTION AMONG INDIVIDUALS WITH CHRONIC HCV INFECTION

Potential for reported needlestick injury prevention among healthcare workers through safety device usage and improvement of guideline adherence: expert panel assessment

1119 QUANTIFYING THE EXTENT OF CIRRHOSIS ATTRIBUTABLE TO ALCOHOL AMONG PATIENTS CHRONICALLY INFECTED WITH HEPATITIS C: IMPLICATIONS FOR TREATMENT COST-EFFECTIVENESS STUDIES

Heart Failure Related Hospitalizations in Children With Single Ventricle Heart Disease in the United States: Costly and Getting More Expensive

867 ARE CURRENT TREATMENT RATES SUFFICIENT TO REDUCE HCV PREVALENCE AMONG PEOPLE WHO INJECT DRUGS? MODEL PROJECTIONS IN SEVEN UK SETTINGS

795 MODELLING THE IMPACT OF ANTIVIRAL THERAPY ON THE FUTURE HEALTH AND ECONOMIC BURDEN OF CHRONIC HEPATITIS C IN SCOTLAND

111: Safety and Effectiveness of Intravenous Prochlorperazine for Intractable Vomiting in Children With Gastroenteritis

Late diagnosis of chronic liver disease in a community cohort (UK biobank): determinants and impact on subsequent survival

MR elastography-based staging of liver fibrosis in Fontan procedure associated liver disease is confounded by effects of venous congestion

Increased risk of non-fatal overdose associated with non-prescribed benzodiazepine use in Scotland, UK

Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic

National population prevalence of antibodies to SARS-CoV-2 in Scotland during the first and second waves of the COVID-19 pandemic

National population prevalence of antibodies to SARS-CoV-2 among pregnant women in Scotland during the second wave of the COVID-19 pandemic: a prospective national serosurvey

FRI-420 - Comparing Individual and Population Prevention Benefits of Early Direct-Acting Antiviral Treatment for HCV

Identifying former injecting drug users infected with hepatitis C: an evaluation of a general practice-based case-finding intervention

O.143 Monitoring of end-stage liver disease associated with hepatitis C virus (HCV) infection in Scotland: Record-linkage study

P71 Choosing an alternate light source with a corresponding dose in photodynamic therapy (it's not rocket science, but it is quantum physics!): determining the PpIX activiation effect

Costs of running a universal adolescent hepatitis B vaccination programme

Ablative Skin Resurfacing

Laser Principles

Determinants of universal adolescent hepatitis B vaccine uptake

Suchergebnisse filtern